Table: Torii Pharmaceutical - 6-MTH parent results
Jul 31 (Reuters)-
Torii Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2023 Jun 30, 2022 Dec 31, 2023
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 25.70 23.10 52.70
(+11.2 pct) (+7.8 pct)
Operating 1.51 2.68 4.10
(-43.7 pct) (+50.0 pct) (-26.0 pct)
Recurring 1.54 2.47 4.40
(-37.5 pct) (+33.3 pct) (-20.5 pct)
Net 1.09 1.85 3.10
(-41.1 pct) (+48.3 pct) (-21.4 pct)
EPS 38.68 yen 65.69 yen 110.32 yen
Ann Div 100.00 yen 100.00 yen
-Q2 div 50.00 yen 24.00 yen
-Q4 div 76.00 yen 50.00 yen
NOTE - Torii Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4551.T
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)